Martina Zigova

Dr. Martina Zigova

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2016 in Molecules
Verified
Journal Article
Open access
PDF file
MZMartina Zigova
Martina Zigova
František ZigoFrantišek Zigo
František Zigo
JMJan Mojzis
Jan Mojzis
Indole phytoalexins from crucifers have been shown to exhibit significant anti-cancer, chemopreventive, and antiproliferative activity. Phytoalexins are natural low molecular antimicrobial compounds that are synthesized and accumulated in plants after their exposure to pathogenic microorganisms. Most interestingly, crucifers appear to be the only plant family producing sulfur-containing indole phytoalexins. The mechanisms underlying its anti-cancer properties are unknown. Isolation from cruciferous plants does not provide sufficient quantities of indole phytoalexins and, for biological screening, they are usually obtainable through synthesis. Understanding the molecular mechanism of the action of these substances and their structure-activity relationships is quite important in the development of new analogs with a more favorable profile of biological activities. In this review, we present the key features of indole phytoalexins, mainly their antiproliferative ativities.

15 November 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
MČMARTINA ČIŽMÁRIKOVÁ
MARTINA ČIŽMÁRIKOVÁ
RMRadka Michalková
Radka Michalková
LMLadislav Mirossay
Ladislav Mirossay
GMGabriela Mojžišová
Gabriela Mojžišová
MZMartina Zigova
Martina Zigova
JMJan Mojzis
Jan Mojzis
Cancer is a complex and multifaceted disease with a high global incidence and mortality rate. Although cancer therapy has evolved significantly over the years, numerous challenges persist on the path to effectively combating this multifaceted disease. Natural compounds derived from plants, fungi, or marine organisms have garnered considerable attention as potential therapeutic agents in the field of cancer research. Ellagic acid (EA), a natural polyphenolic compound found in various fruits and nuts, has emerged as a potential cancer prevention and treatment agent. This review summarizes the experimental evidence supporting the role of EA in targeting key hallmarks of cancer, including proliferation, angiogenesis, apoptosis evasion, immune evasion, inflammation, genomic instability, and more. We discuss the molecular mechanisms by which EA modulates signaling pathways and molecular targets involved in these cancer hallmarks, based on in vitro and in vivo studies. The multifaceted actions of EA make it a promising candidate for cancer prevention and therapy. Understanding its impact on cancer biology can pave the way for developing novel strategies to combat this complex disease.

19 May 2024 in Molecules
Verified
Journal Article
Open access
PDF file
MZMartina Zigova
Martina Zigova
RMRadka Michalková
Radka Michalková
JMJan Mojzis
Jan Mojzis
Indole phytoalexins, found in economically significant Cruciferae family plants, are synthesized in response to pathogen attacks or stress, serving as crucial components of plant defense mechanisms against bacterial and fungal infections. Furthermore, recent research indicates that these compounds hold promise for improving human health, particularly in terms of potential anticancer effects that have been observed in various studies. Since our last comprehensive overview in 2016 focusing on the antiproliferative effects of these substances, brassinin and camalexin have been the most extensively studied. This review analyses the multifaceted pharmacological effects of brassinin and camalexin, highlighting their anticancer potential. In this article, we also provide an overview of the antiproliferative activity of new synthetic analogs of indole phytoalexins, which were synthesized and tested at our university with the aim of enhancing efficacy compared to the parent compound.

13 April 2024 in Molecules
Verified
Journal Article
Open access
PDF file
MZMartina Zigova
Martina Zigova
VMViktória Miškufová
Viktória Miškufová
MBMarianna Budovská
Marianna Budovská
RMRadka Michalková
Radka Michalková
JMJan Mojzis
Jan Mojzis
Ovarian cancer, a highly lethal malignancy among reproductive organ cancers, poses a significant challenge with its high mortality rate, particularly in advanced-stage cases resistant to platinum-based chemotherapy. This study explores the potential therapeutic efficacy of 1-methoxyisobrassinin (MB-591), a derivative of indole phytoalexins found in Cruciferae family plants, on both cisplatin-sensitive (A2780) and cisplatin-resistant ovarian cancer cells (A2780 cis). The findings reveal that MB-591 exhibits an antiproliferative effect on both cell lines, with significantly increased potency against cisplatin-sensitive cells. The substance induces alterations in the distribution of the cell cycle, particularly in the S and G2/M phases, accompanied by changes in key regulatory proteins. Moreover, MB-591 triggers apoptosis in both cell lines, involving caspase-9 cleavage, PARP cleavage induction, and DNA damage, accompanied by the generation of reactive oxygen species (ROS) and mitochondrial dysfunction. Notably, the substance selectively induces autophagy in cisplatin-resistant cells, suggesting potential targeted therapeutic applications. The study further explores the interplay between MB-591 and antioxidant N-acetylcysteine (NAC), in modulating cellular processes. NAC demonstrates a protective effect against MB-591-induced cytotoxicity, affecting cell cycle distribution and apoptosis-related proteins. Additionally, NAC exhibits inhibitory effects on autophagy initiation in cisplatin-resistant cells, suggesting its potential role in overcoming resistance mechanisms.

28 November 2023 in Journal of Applied Animal Research
Verified
Journal Article
Open access
ZKZeinab Kamal
Zeinab Kamal
ZAZeinab Al-Amgad
Zeinab Al-Amgad
František ZigoFrantišek Zigo
František Zigo
ZFZuzana Farkašová
Zuzana Farkašová
MZMartina Zigova
Martina Zigova
IRIbrahim Rehan
Ibrahim Rehan

1 January 2026 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
IRIbrahim Rehan
Ibrahim Rehan
František ZigoFrantišek Zigo
František Zigo
ZLZuzana Lacková
Zuzana Lacková
MZMartina Zigova
Martina Zigova
Rehan IF, et al. J Vet Sci. 2026 ;27:e68. https://doi.org/10.4142/jvs.25236